- Founders: Dr. Ashish Rawandale & Dr. Preeti Rawandale
- Business: Medical Device
- Ask: ₹ 60 Lakhs for 1% Equity
- Valuation: ₹60 Crore
- Result: ₹ 60 Lakhs for 6% Equity
- Sharks: Namita Thapar and Amit Jain
- Episode: Season 2 Episode 15
P-flow Shark Tank India Pitch:
P-Flow is a urology innovation that provides a disposable and conventional kit for urine flow tests. P-Flow eliminates the need for patients to make 2-3 visits a month to hospitals for Uroflowmetry tests because they can perform this test at home. It is the world’s first portable and disposable test kit, which could potentially replace the traditional Uroflowmetry test. Patients can conduct the test at home, and the results will be available on their mobile phones. The company’s vision is to make P-Flow available worldwide.
P-Flow is available through the company’s website and on Amazon. They have an accuracy rate of over 95%. The average cost of P-Flow is ₹1000, which is on par with traditional tests, but P-Flow can be used three times, resulting in a cost of around ₹200 and a gross margin of approximately 80%. They have sold 650 cases so far in their own hospital and other known places. Projections for the company indicate revenue of 5 lakhs per day. This deal would require a new structure since Dr. Ashish Rawandale already had a publicly listed company with 125 crores in revenue, but all his intellectual property and patents for this product were under his personal name.
P-Flow Shark Tank Negotiations:
Amit Jain made the first offer with Namita joining because she believes this could have a global impact. However, their offer came with the condition that they needed to restructure the company and its patents. Their initial offer was ₹60 lakhs for 10% of the company. Peyush declined the offer, citing the complex company/deal structure. Anupam had the same reasons for not accepting the deal, and Aman went out, thinking that the product wasn’t a market fit yet. The company requested a moment to think about it, to which Namita added that the offer would be non-negotiable.
The entrepreneurs came back with a counteroffer of 3%. Namita rejected it and countered at 8%, which the entrepreneurs also rejected. Anupam asked if there was any room for negotiation, to which the company responded with a little. Amit suggested a final counteroffer of 6% of the company for ₹60 lakhs, and the company accepted that offer at 6%.
Did the deal with the sharks close? Let’s find out!
How is P-Flow doing after Shark Tank India?
Our research into the company revealed that the deal with the sharks never closed. It appears that, in the end, the entrepreneurs decided not to create separate entities for P-Flow and instead launched it under their already existing company, ‘Tejnaksh Healthcare.’ As of the last available report, the company achieved revenue of 12.03 crores in FY22-23 with a net profit of 1.79 crores. However, their revenue for FY21-22 was 12.82 crores, with profits amounting to 2.81 crores.
What do you think might be the reason why this deal did not go through? Feel free to share your thoughts in the comment section below.”
Source: tejnaksh.com
Click here for updates on other companies from Shark Tank India season 2!
1 thought on “How is P-Flow doing after Shark Tank India?”